The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Utilizing a novel four-drug regimen to reduce the incidence of infusion-related reactions for first-dose rituximab infusions: An institutional review of rituximab infusion-related reactions in lymphoma patients.
 
Trace Bartels
No Relationships to Disclose
 
Logan Moore
No Relationships to Disclose
 
Daniel Oscar Persky
Consulting or Advisory Role - Bayer; Celgene; Cellectar; Debiopharm Group; kymera; MorphoSys
Research Funding - Merck (Inst)
 
Abhijeet Kumar
No Relationships to Disclose
 
Ivo Abraham
Consulting or Advisory Role - Celgene (Inst); Coherus Biosciences (Inst); Janssen Scientific Affairs (Inst); Novartis (Inst); Rockwell Medical (Inst); Sandoz (Inst); TERUMO (Inst)
Speakers' Bureau - Coherus Biosciences (Inst)
 
Ali McBride
Speakers' Bureau - Coherus BioSciences